Clinicopathologic significance and race-specific prognostic association of MYB overexpression in ovarian cancer

Late diagnosis, unreliable prognostic assessment, and poorly-guided therapeutic planning result in dismal survival of ovarian cancer (OC) patients. Therefore, identifying novel functional biomarker(s) is highly desired for improved clinical management. MYB is an oncogenic transcription factor with e...

Descripción completa

Detalles Bibliográficos
Autores principales: Miree, Orlandric, Srivastava, Sanjeev Kumar, Khan, Mohammad Aslam, Sameeta, Fnu, Acharya, Srijan, Ndetan, Harrison, Singh, Karan Pal, Hertweck, Kate Louise, Dasgupta, Santanu, da Silva, Luciana Madeira, Rocconi, Rodney Paul, Carter, James Elliot, Singh, Seema, Singh, Ajay Pratap
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213794/
https://www.ncbi.nlm.nih.gov/pubmed/34145334
http://dx.doi.org/10.1038/s41598-021-92352-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213794/
https://www.ncbi.nlm.nih.gov/pubmed/34145334
http://dx.doi.org/10.1038/s41598-021-92352-3

Ejemplares similares